Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Am J Obstet Gynecol. 2010 Nov 3;204(1):56.e1–56.e6. doi: 10.1016/j.ajog.2010.08.023

Table 5.

Unadjusted and adjusted logistic regression analysis for outcome PPH secondary to uterine atony

Predictor Denom/Numerator
of OR
Unadjusted OR
(95% CI)
p-value
Adjusted OR
(95% CI)
p-value
Oxytocin AUC 5000 mU increase 1.47 (1.17, 1.93)
<0.001
1.58 (1.05, 2.57)
0.026
Race Hispanic/Caucasian 5.25 (1.69, 16.39)
0.005
1.36 (0.41, 5.59)
0.540
BMI 1-unit increase 0.94 (0.88, 1.01)
0.11
0.97 (0.89, 1.04)
0.449
Admission Hematocrit 1-unit increase 0.86 (0.77, 0.95)
0.004
0.05 (0.002, 0.93)
0.044
Induction status Yes/No 2.17 (0.95, 5.06)
0.063
1.16 (0.34, 3.78)
0.803
Preeclampsia Yes/No 4.90 (1.66, 14.43)
<0.001
*
Magnesium therapy Yes/No 3.43 (1.14, 10.34)
<0.001
1.17 (0.27, 5.34)
0.832
Chorioamnionitis Yes/No 2.10 (0.93, 10.50)
0.30
4.38 (0.42, 58.5)
0.217
*

Not included in adjusted analysis since preeclampsia and magnesium therapy are dependent on each other